The ongoing rethinking of the rules governing herbal products in Australia has highlighted more than 30 herbs for safety review, according
to the Therapeutic Goods Administration (TGA).

Chad was a Marine Scout Sniper who served two tours in Iraq. Upon being honorably discharged as a Sgt. in 2007, he summoned the courage to
ask for help in dealing with the images and emotions that gnawed on him from being dropped into combat. Like so many of his peers, the help
he was given was “meds.” Although Chad was used to putting his life at risk, he never expected that his life would be more directly
threatened by the “treatment” he was offered—psychiatric drugs.

Researchers have discovered that African American children with asthma in metropolitan Washington, DC, are significantly more likely to
have low levels of vitamin D than healthy children.

A legal expert has questioned whether litigants other than lead plaintiff Graeme Peterson will benefit from the recent Vioxx judgement against Merck Sharp & Dohme (MSD).

The Health Department has confirmed that high level discussions are under way to "strengthen the harmonisation of therapeutic product standards between Australia and New Zealand" despite the abandonment Australia and New Zealand Therapeutic Products Authority (ANZTPA) project in 2007.

See how Monsanto is claiming a patent on pigs (your read that right) and is seeking a monopoly on the world's food supply. There are serious questions about the effect of their genetic engineering on human health.

Exposure to certain chemicals and pollutants before a woman reaches her mid-30s could treble her risk of developing breast cancer after the menopause, Canadian scientists said on Thursday.

Not all Easter chocolate is created equal, so it pays to know your eggs. And don't believe that just because it looks like chocolate and smells like chocolate that it is chocolate.

There has been comment of late about the FDA’s refusal — under the guise of protecting trade secrets — to notify practitioners and consumers about defective medical devices. But that controversy pales in comparison with the scandal now swirling around Menaflex, a device intended to fix a torn meniscus. It is manufactured by the company ReGen Biologics, of Hackensack, N.J.

In a landmark case that could shift the dividing line between prescription and complementary medicines, Sylvan Health is taking the Therapeutic Goods Administration to the Federal Court.